Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2017-11-02 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75020), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE DE CHARONNE : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE DE CHARONNE is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75020),
this company of category PME
shows in 2022 a net income positive of 72 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE DE CHARONNE (SIREN 832709521)
Indicator
2022
2021
2019
2018
Revenue
N/C
N/C
N/C
N/C
Net income
72 400 €
67 911 €
59 007 €
36 283 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE CENTRALE DE CHARONNE generates positive net income of 72 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2022: 36 k€ -> 72 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
72 400 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 301%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. The balance between equity and debt is satisfactory.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
301.277%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
20.296%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE DE CHARONNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2021
2022
Debt ratio
1212.291
649.59
447.746
301.277
Financial autonomy
6.445
10.657
15.519
20.296
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
301.282022
2019
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average
In 2022, the debt ratio of PHARMACIE CENTRALE DE CHA... (301.28) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
20.3%2022
2019
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Average
In 2022, the financial autonomy of PHARMACIE CENTRALE DE CHA... (20.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 148.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
148.533
Liquidity indicators evolution PHARMACIE CENTRALE DE CHARONNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2021
2022
Liquidity ratio
152.247
122.961
171.544
148.533
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
148.532022
2019
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Average
In 2022, the liquidity ratio of PHARMACIE CENTRALE DE CHA... (148.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE CENTRALE DE CHARONNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE CENTRALE DE CHARONNE is estimated at
851 895 €
(range 572 642€ - 1 277 684€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
572k€851k€1277k€
851 895 €Range: 572 642€ - 1 277 684€
NAF 5 année 2022
Valuation method used
Net Income Multiple
72 400 €
×
11.8x
=851 895 €
Range: 572 643€ - 1 277 685€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE DE CHARONNE with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE DE CHARONNE
What is the revenue of PHARMACIE CENTRALE DE CHARONNE ?
The revenue of PHARMACIE CENTRALE DE CHARONNE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE DE CHARONNE profitable?
Yes, PHARMACIE CENTRALE DE CHARONNE generated a net profit of 72 k€ in 2022.
Where is the headquarters of PHARMACIE CENTRALE DE CHARONNE ?
The headquarters of PHARMACIE CENTRALE DE CHARONNE is located in PARIS (75020), in the department Paris.
Where to find the tax return of PHARMACIE CENTRALE DE CHARONNE ?
The tax return of PHARMACIE CENTRALE DE CHARONNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE DE CHARONNE operate?
PHARMACIE CENTRALE DE CHARONNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart